Completed PHASE4 INTERVENTIONAL 2-arm NCT02709603

Hyoscine Butyl Bromide in Reducing Pain During HSG (HBTB-DIC)

Randomized Clinical Trial of Oral Hyoscine Butyl Bromide in Reducing Pain During HSG

Sponsor: Assiut University

Interventions hyoscine butyl bromide placebo

Updated 7 times since 2017 Last updated: Sep 6, 2016 Started: Mar 31, 2016 Primary completion: May 31, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain Relief With HSG and is currently completed. Assiut University leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Assiut, Egypt
• Asyut, Egypt